Bleakley Financial Group, LLC

Position in ALKS — Alkermes plc.

CIK 1936953 PARSIPPANY, NJ

Position in ALKS

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$355,863

-$56,338 QoQ

Shares Held

10,064

-31.7% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Bleakley Financial Group, LLC holds $14,751,437 across 10 Drug Manufacturers - Specialty & Generic names. ALKS ranks #8 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	431,602	$7,993,269
2	ZTS	Zoetis Inc.	18,748	$2,216,201
3	LNTH	Lantheus Holdings, Inc.	13,951	$1,058,183
4	LQDA	Liquidia Corp	22,855	$862,547
5	PBH	Prestige Consumer Healthcare Inc.	12,245	$725,761
6	AQST	Aquestive Therapeutics, Inc.	135,767	$563,433
7	HROW	Harrow, Inc.	13,183	$464,832
8	ALKS	Alkermes plc. This page	10,064	$355,863

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$355,863	10,064	-31.7%	Shares	Sole	2026-05-04
2025-12-31	$412,201	14,732	+19.6%	Shares	Sole	2026-02-09
2025-09-30	$369,540	12,318	-12.4%	Shares	Sole	2025-11-10
2025-06-30	$402,285	14,061	-10.7%	Shares	Sole	2025-07-30
2025-03-31	$519,866	15,744	-0.7%	Shares	Sole	2025-05-01
2024-12-31	$455,817	15,849	+37.6%	Shares	Sole	2025-01-27
2024-09-30	$322,276	11,514	-0.4%	Shares	Sole	2024-10-16
2024-06-30	$278,668	11,563	-4.8%	Shares	Sole	2024-08-12
2024-03-31	$328,765	12,145	+3.0%	Shares	Sole	2024-05-08
2023-12-31	$327,110	11,792	-9.7%	Shares	Sole	2024-01-25
2023-09-30	$365,810	13,060	-19.0%	Shares	Sole	2023-11-14
2023-06-30	$504,399	16,115	+21.9%	Shares	Sole	2023-08-14
2023-03-31	$372,671	13,220	+11.6%	Shares	Sole	2023-05-12
2022-12-31	$309,535	11,846	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.